MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping
Biomolecules · 2025
DOI: 10.3390/biom15050687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Martina Mietto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Unit, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Rett Syndrome, Brain, RNA, Messenger. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rett syndrome (RTT) is a rare X-linked dominant neurodevelopmental disorder caused by pathogenic variants in the methyl-CpG-binding protein 2 (MECP2) gene, which encodes a methyl-CpG-binding protein (MeCP2) that acts as a repressor of gene expression, crucial in neurons. Dysfunction of MeCP2 due to its pathogenic variants explains the clinical features of RTT. Here, we performed histological and RNA analyses on a post-mortem brain sample from an RTT patient carrying the p.Arg106Trp missense mutation. This patient is part of a cohort of 56 genetically and clinically characterized RTT patients, for whom we provide an overview of the mutation landscape. In the RTT brain specimen, RT-PCR analysis detected preferential transcription of the mutated mRNA. X-inactivation studies revealed a skewed X-chromosome inactivation ratio (95:5), supporting the transcriptional findings. We also mapped the MECP2 transcript in control human brain regions (temporal cortex and cerebellum) using the RNAscope assay, confirming its high expression. This study reports the MECP2 transcript representation in a post-mortem RTT brain and, for the first time, the in situ MECP2 transcript localization in a human control brain, offering insights into how specific MECP2 mutations may differentially impact neuronal functions. We suggest these findings are crucial for developing RNA-based therapies for Rett syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Unit, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
- Pathology Institute, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Institute of Genetics and Biophysics "A. Buzzati-Traverso", CNR, 80131 Naples, Italy.
- The Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London WC1E 6BT, UK.
- Child Neuropsychiatry Unit, University Hospital, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.
ORCID-Profile: Silvia Montanari, Maria Sofia Falzarano, Rita Selvatici, Francesca Gualandi, Marcella Neri, Fernanda Fortunato, Miryam Rosa Stella Foti, Marcella Vacca, Silvia Torelli, Alessandra Ferlini
Zitieren
APA
Mietto, M., Montanari, S., Falzarano, M. S., Manzati, E., Rimessi, P., Fabris, M., Selvatici, R., Gualandi, F., Neri, M., Fortunato, F., Foti, M. R. S., Bigoni, S., Gessi, M., Vacca, M., Torelli, S., Hayek, J., & Ferlini, A. (2025). MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping. Biomolecules. https://doi.org/10.3390/biom15050687
Vancouver
Mietto M, Montanari S, Falzarano MS, Manzati E, Rimessi P, Fabris M, et al. MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping. Biomolecules. 2025. doi:10.3390/biom15050687
BibTeX
@article{Mietto2025,
author = {Mietto, Martina and Montanari, Silvia and Falzarano, Maria Sofia and Manzati, Elisa and Rimessi, Paola and Fabris, Marina and Selvatici, Rita and Gualandi, Francesca and Neri, Marcella and Fortunato, Fernanda and Foti, Miryam Rosa Stella and Bigoni, Stefania and Gessi, Marco and Vacca, Marcella and Torelli, Silvia and Hayek, Joussef and Ferlini, Alessandra},
title = {MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15050687}
}
EUVIMED